Children’s Cancer Research Fund (CCRF) is a national nonprofit committed to finding safer, more effective therapies for kids battling cancer. Thanks to donors and partners around the country, we have contributed $186 million to research, education and awareness, and quality-of-life programs for childhood cancer families. We believe kids deserve safer, less toxic treatments, and we’re committed to funding groundbreaking research and services that enhance healing and care.

CCRF welcomes applications in the following grant categories: hard-to-treat cancers and emerging scientists. These award programs are developed with our Research Advisory Committee (RAC).

All Letters of Intent and Applications must be submitted through ProposalCENTRAL. Each application is peer reviewed, and the RAC will make funding recommendations to the CCRF Board of Directors.

Please email grants@childrenscancer.org with any questions about our award programs or the application process.

Accelerating Impact for Hard to Treat Cancers Award

Treatment success against hard-to-treat cancers has remained out of reach. This grant mechanism supports basic, clinical, and population studies. Projects may include pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. A Hard-to-Treat Award is $250,000 for a two-year period.

CCRF defines hard-to-treat cancer as 5-year survival less than 70% in an individual cancer (e.g. osteosarcoma, AML, DIPG), in a cancer with unfavorable behavior (e.g. relapse or metastasis), or in a molecular defined subtype (e.g. MLL rearranged leukemia, PAX3-FOXO1 rearranged RMS).  Cancers with survival <70% in demographic groups defined by age, sex, or race/ethnicity may also qualify if a biologic hypothesis is being pursued.

Please review the award and eligibility information in the funding announcement before submitting a Letter of Intent.

Letters of Intent will be peer reviewed to determine which applicants will be invited to submit a full application.

Letters of Intent will be accepted from August 31, 2020 through September 17, 2020 at Noon (Central time). Invited applications are due by November 25, 2020. Award recipients will be notified in early February 2021. Detailed timing is in the funding announcement.

Emerging Scientist Award

This award is designed to develop the independent research of highly qualified individuals still early in their careers. An Emerging Scientist Award is $100,000 for a one-year period.

Applicants should hold a post-graduate doctoral degree in a field of medicine or scientific research specialty and be a faculty member at an accredited university. Applicants must be within the first 7 years of their initial independent full faculty appointment at the time the award begins.

Please review both the funding announcement and the application instructions before submitting an application.

Emerging Scientist Award applications will be accepted from August 17 through September 17, 2020 at Noon (Central time). Award recipients will be notified in late November 2020. Detailed timing is in the funding announcement.

Submitting an Application

All applications for CCRF awards must be submitted through ProposalCENTRAL. Each application is peer reviewed, and the Research Advisory Committee will make funding recommendations to the CCRF Board of Directors.

Please email grants@childrenscancer.org with any questions about our award programs or the application process.